These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1405232)

  • 1. [Anti-arrhythmia agents in heart failure].
    Brakhmann I; Shmitt K; Baĭer T; Valdeker B; Khilbel T; ShvaĭtserM ; Kiubler V
    Kardiologiia; 1992 Apr; 32(4):38-40. PubMed ID: 1405232
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiarrhythmic drug therapy of ventricular arrhythmias.
    Huang SK; Marcus FI
    Curr Probl Cardiol; 1986 Apr; 11(4):177-240. PubMed ID: 3086035
    [No Abstract]   [Full Text] [Related]  

  • 3. Update: cardiac antiarrhythmic drugs.
    Liem LB; Kates RE
    Compr Ther; 1989 Apr; 15(4):17-27. PubMed ID: 2495883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular arrhythmias. An assessment of newer therapeutic agents.
    Skluth H; Grauer K; Gums J
    Postgrad Med; 1989 May; 85(6):137-8, 141-8, 153. PubMed ID: 2496401
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiarrhythmic agents for chronic ventricular arrhythmias.
    Nestico PF; Morganroth J
    Compr Ther; 1987 Apr; 13(4):26-35. PubMed ID: 3105950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
    Eur Heart J; 1992 Sep; 13(9):1251-8. PubMed ID: 1396837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drugs in the management of ventricular arrhythmias.
    Sanna GP
    G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic drugs in the management of atrial fibrillation.
    Cowan JC
    Br Heart J; 1993 Oct; 70(4):304-6. PubMed ID: 8217437
    [No Abstract]   [Full Text] [Related]  

  • 10. Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone.
    Neri R; Mestroni L; Salvi A; Pandullo C; Camerini F
    Am Heart J; 1987 Mar; 113(3):707-15. PubMed ID: 3825860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of anti-arrhythmia agents on heart rate. Significance and importance].
    Leclercq JF; Georgiopoulos G; Halkidis H; Attuel P; Maisonblanche P; Coumel P
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():37-46. PubMed ID: 6122434
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine].
    Mondillo S; Faglia S; D'Aprile N; Mangiacotti L; Campolo MA; Agricola E; Palazzuoli V
    Clin Ter; 1995 Dec; 146(12):769-74. PubMed ID: 8681496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of arrhythmia in coronary cardiopathy].
    Lüderitz B
    Clin Ter; 1983 Apr; 105(1):3-11. PubMed ID: 6189663
    [No Abstract]   [Full Text] [Related]  

  • 14. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of treatment with propafenone, metoprolol and amiodarone on lymphocyte sodium efflux and level of cAMP in serum].
    Kosmala W
    Pol Arch Med Wewn; 1995 Jul; 94(1):14-20. PubMed ID: 8524694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a need for new antiarrhythmic drugs?
    Roden DM
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arrhythmias in cardiomyopathy and specific myocardial diseases].
    Yamaoki K; Yazaki Y
    Nihon Rinsho; 1991 Nov; 49(11):2622-9. PubMed ID: 1770599
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of patients with acute atrial fibrillation in the ED.
    Conti A; Del Taglia B; Mariannini Y; Pepe G; Vanni S; Grifoni S; Abbate R; Michelucci A; Padeletti L; Gensini GF
    Am J Emerg Med; 2010 Oct; 28(8):903-10. PubMed ID: 20825922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches.
    Kowey PR; Yan GX; Winkel E; Kao W
    Am J Cardiol; 2003 Mar; 91(6A):33D-38D. PubMed ID: 12670640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Validity and limits of invasive pharmacological tests in the treatment of malignant ventricular hyperkinetic arrhythmias].
    Disertori M; Vergara G; Inama G; Guarnerio M; Furlanello F; Botti G; Bonatti V; Rolli A
    G Ital Cardiol; 1983; 13(4):311-4. PubMed ID: 6884675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.